
Afzanna 30mg Tablet
Marketer
Celon Laboratories Ltd
Salt Composition
Afatinib dimaleate (30mg)
Overview Afzanna 30mg Tablet
Erlotinib 30mg tablets are indicated for treating non-small cell lung cancer in adults with specific epidermal growth factor receptor (EGFR) gene mutations. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency will be determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be apparent for several weeks or months; discontinue use only under your doctor's guidance. Common side effects include nausea, diarrhea, skin rash, and dryness. Severe diarrhea requires prompt medical attention, including appropriate medication and hydration. Regular blood tests may be necessary. Photosensitivity is possible; utilize sunscreen and protective clothing when exposed to sunlight. Report any eye pain, redness, or dryness to your doctor immediately. Prior to commencing treatment, disclose any respiratory issues, hepatic or renal impairment, or concurrent use of anti-infective medications. Potential drug interactions exist; inform your healthcare provider of all medications you are currently taking. This medication is contraindicated during pregnancy and breastfeeding. Women of childbearing potential must utilize effective contraception throughout treatment.
Primary Ingredients of Afzanna 30mg Tablet
No text provided to rephrase.
Uses of Afzanna 30mg Tablet
Lung cancer (excluding small cell type)
Major Benefits of Afzanna 30mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Afzanna 30mg Tablet on an empty stomach.
Common Side effects of Afzanna 30mg Tablet:
- Diarrhea
- Rash
- Dry skin
- Nausea
- Vomiting
- Loss of appetite
- Itching
- Stomatitis (Inflammation of the mouth)
- Nail disorder
How to use Afzanna 30mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Afzanna 30mg Tablet on an empty stomach.
How Afzanna 30mg Tablet works:
Afzanna 30mg tablets are a cancer treatment that functions by attaching to and blocking key enzyme receptors (EGFR, HER2, and HER4) which drive cancer cell proliferation. This action suppresses associated signaling pathways, thereby hindering or slowing cancer progression.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Afzanna 30mg Tablets presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Using Afzanna 30mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances where the potential benefits outweigh the risks, a physician may prescribe it. Always seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Afzanna 30mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
Afzanna 30mg Tablet's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Afzanna 30mg Tablet in patients with kidney impairment is likely safe. Existing evidence indicates dose modification may not be necessary, however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Afzanna 30mg tablets appear to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Afzanna 30mg Tablet :
Omit any missed Afzanna 30mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Afzanna 30mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Butenamide-Quinazoline Hybrid |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | TKIs (Tyrosine Kinase Inhibitors) |
